{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:38:26Z","timestamp":1787031506307,"version":"build-2736575974"},"reference-count":25,"publisher":"Jaypee Brothers Medical Publishing","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,1]]},"DOI":"10.5005\/jp-journals-10080-1445","type":"journal-article","created":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T23:15:13Z","timestamp":1609542913000},"page":"121-125","source":"Crossref","is-referenced-by-count":10,"title":["Limb-saving Knee Arthrodesis with a Silver-coated Arthrodesis Rod in a Patient with Aspergillus Osteomyelitis of the Knee"],"prefix":"10.5005","volume":"15","author":[{"given":"Abdullah","family":"Ismat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Alt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Heiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Rupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","published-online":{"date-parts":[[2020]]},"reference":[{"key":"ref=1","unstructured":"1. Heinekamp T, Schmidt H, Lapp K, et al., Interference of and#x003C;iand#x003E;Aspergillus fumigatusand#x003C;\/iand#x003E; with the immune response. Paper presented at: Seminars in immunopathology 2015."},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"2. Fernstrom A, Goldblatt M. Aerobiology and its role in the transmission of infectious diseases. Journal of pathogens 2013;2013.","DOI":"10.1155\/2013\/493960"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"3. Geiser DM. Sexual structures in and#x003C;iand#x003E;Aspergillusand#x003C;\/iand#x003E;: morphology, importance and genomics. Med Mycol 2009;47(Suppl 1):S21and#x2013;S26. DOI: 10.1080\/13693780802139859.","DOI":"10.1080\/13693780802139859"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"4. Maschmeyer G, Haas A, Cornely OA. Invasive aspergillosis. Drugs 2007;67(11):1567and#x2013;1601. DOI: 10.2165\/00003495-200767110-00004.","DOI":"10.2165\/00003495-200767110-00004"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"5. Gabrielli E, Fothergill AW, Brescini L, et al. Osteomyelitis caused by and#x003C;iand#x003E;Aspergillusand#x003C;\/iand#x003E; species: a review of 310 reported cases. Clin Microbiol Infect 2014;20(6):559and#x2013;565. DOI: 10.1111\/1469-0691.12389.","DOI":"10.1111\/1469-0691.12389"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"6. Bariteau JT, Waryasz GR, McDonnell M, et al. Fungal osteomyelitis and septic arthritis. J Am Acad Orthop Surg 2014;22(6):390and#x2013;401. DOI: 10.5435\/JAAOS-22-06-390.","DOI":"10.5435\/JAAOS-22-06-390"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"7. Gamaletsou MN, Rammaert B, Bueno MA, et al. and#x003C;iand#x003E;Aspergillusand#x003C;\/iand#x003E; osteomyelitis: epidemiology, clinical manifestations, management, and outcome. J Infect 2014;68(5):478and#x2013;493. DOI: 10.1016\/j.jinf.2013.12.008.","DOI":"10.1016\/j.jinf.2013.12.008"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"8. Sheehy SH, Atkins BA, Bejon P, et al. The microbiology of chronic osteomyelitis: prevalence of resistance to common empirical anti-microbial regimens. J Infect 2010;60(5):338and#x2013;343. DOI: 10.1016\/j.jinf.2010.03.006.","DOI":"10.1016\/j.jinf.2010.03.006"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"9. Giger A, Yusuf E, Manuel O, et al. Polymicrobial vertebral osteomyelitis after oesophageal biopsy: a case report. BMC Infect Dis 2016;16(1):141. DOI: 10.1186\/s12879-016-1471-9.","DOI":"10.1186\/s12879-016-1471-9"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"10. Patterson TF, Thompson GR, Denning DW, et al. Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America. Clin Infect Dis 2016;63(4): e1and#x2013;e60. DOI: 10.1093\/cid\/ciw326.","DOI":"10.1093\/cid\/ciw326"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"11. Lew DP, Waldvogel FA. Osteomyelitis. Lancet 2004;364(9431):369and#x2013;379. DOI: 10.1016\/S0140-6736(04)16727-5.","DOI":"10.1016\/S0140-6736(04)16727-5"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"12. Koehler P, Tacke D, Cornely OA. Aspergillosis of bones and jointsand#x2013;a review from 2002 until today. Mycoses 2014;57(6):323and#x2013;335. DOI: 10.1111\/myc.12165.","DOI":"10.1111\/myc.12165"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"13. Haidar R, Der Boghossian A, Atiyeh B. Duration of post-surgical antibiotics in chronic osteomyelitis: empiric or evidence-based? Int J Infect Dis 2010;14(9):e752and#x2013;e758. DOI: 10.1016\/j.ijid.2010.01.005.","DOI":"10.1016\/j.ijid.2010.01.005"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"14. Brady RA, Leid JG, Calhoun JH, et al. Osteomyelitis and the role of biofilms in chronic infection. Pathog Dis 2008;52(1):13and#x2013;22. DOI: 10.1111\/j.1574-695X.2007.00357.x.","DOI":"10.1111\/j.1574-695X.2007.00357.x"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"15. Sealy PI, Nguyen C, Tucci M, et al. Delivery of antifungal agents using bioactive and nonbioactive bone cements. Ann Pharmacother 2009;43(10):1606and#x2013;1615. DOI: 10.1345\/aph.1M143.","DOI":"10.1345\/aph.1M143"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"16. Grimsrud C, Raven R, Fothergill A, et al. The in vitro elution characteristics of antifungal-loaded PMMA bone cement and calcium sulfate bone substitute. Orthopedics 2011;34(8):e378and#x2013;e381. DOI: 10.3928\/01477447-20110627-05.","DOI":"10.3928\/01477447-20110627-05"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"17. Rouse MS, Heijink A, Steckelberg JM, et al. Are anidulafungin or voriconazole released from polymethylmethacrylate in vitro? Clin Orthopaed Relat Res 2011;469(5):1466and#x2013;1469. DOI: 10.1007\/s11999-010-1643-7.","DOI":"10.1007\/s11999-010-1643-7"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"18. Wafa H, Grimer RJ, Reddy K, et al. Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients. Bone Joint J 2015;97(2):252and#x2013;257. DOI: 10.1302\/0301-620X.97B2.34554.","DOI":"10.1302\/0301-620X.97B2.34554"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"19. Hardes J, Von Eiff C, Streitbuerger A, et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol 2010;101(5):389and#x2013;395. DOI: 10.1002\/jso.21498.","DOI":"10.1002\/jso.21498"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"20. Alt V, Bechert T, Steinrand#x00FC;cke P, et al. An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement. Biomaterials 2004;25(18):4383and#x2013;4391. DOI: 10.1016\/j.biomaterials.2003.10.078.","DOI":"10.1016\/j.biomaterials.2003.10.078"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"21. Panand#x00E1;and#x010D;ek A, Koland#x00E1;and#x0159; M, Veand#x010D;eand#x0159;ovand#x00E1; R, et al. Antifungal activity of silver nanoparticles against Candida spp. Biomaterials 2009;30(31): 6333and#x2013;6340. DOI: 10.1016\/j.biomaterials.2009.07.065.","DOI":"10.1016\/j.biomaterials.2009.07.065"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"22. Ogar A, Tylko G, Turnau K. Antifungal properties of silver nanoparticles against indoor mould growth. Sci Total Environm 2015;521:305and#x2013;314. DOI: 10.1016\/j.scitotenv.2015.03.101.","DOI":"10.1016\/j.scitotenv.2015.03.101"},{"key":"ref=23","unstructured":"23. Khalilpour P, Lampe K, Wagener M, et al. Ag\/SiOand#x003C;suband#x003E;xand#x003C;\/suband#x003E;Cand#x003C;suband#x003E;yand#x003C;\/suband#x003E; plasma polymer coating for antimicrobial protection of fracture fixation devices. J Biomed Mater Res Part B Appl Biomater 2010;94(1):196and#x2013;202."},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"24. Glehr M, Leithner A, Friesenbichler J, et al. Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J 2013;95(7):988and#x2013;992. DOI: 10.1302\/0301-620X.95B7.31124.","DOI":"10.1302\/0301-620X.95B7.31124"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"25. Zhang C, Chen M, Wang G, et al. Pd@ ag Nanosheets in combination with amphotericin B exert a Potent anti-Cryptococcal Fungicidal effect. PLoS ONE 2016;11(6):e0157000. DOI: 10.1371\/journal.pone.0157000.","DOI":"10.1371\/journal.pone.0157000"}],"container-title":["Strategies in Trauma and Limb Reconstruction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.stlrjournal.com\/doi\/pdf\/10.5005\/jp-journals-10080-1445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T18:32:20Z","timestamp":1622745140000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.stlrjournal.com\/doi\/10.5005\/jp-journals-10080-1445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020]]}},"alternative-id":["10.5005\/jp-journals-10080-1445"],"URL":"https:\/\/doi.org\/10.5005\/jp-journals-10080-1445","relation":{},"ISSN":["1828-8936","1828-8928"],"issn-type":[{"value":"1828-8936","type":"print"},{"value":"1828-8928","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}